Glepaglutide

Glepaglutide (ZP1848) is a long-acting GLP-2 receptor agonist that enhances intestinal absorption and reduces inflammation. It is a valuable research tool for studying intestinal function and pathology in models of inflammatory bowel disease (IBD) and short bowel syndrome.